Daily non-political popular news in brief.
UAB research could improve the prognosis and treatment of lung cancer
01-07-2008 · EurekAlert!A group of scientists at the Universitat Autònoma de Barcelona, has published research on an enzyme that is detected in large quantities only in lung cancers. This enzyme can appear even when the cancer has not yet developed. Thus this molecule would serve as a good marker in the diagnosis and prognosis of the disease. The research is of great interest for potential future therapeutical applications as well.
Read more »
Keywords: uab, research, improve, prognosis, treatment, lung, cancer, prognosi
« Previous | Next »
Similar news on "UAB research could improve the prognosis and treatment of lung cancer":
- Research suggests new treatment suitable for all patients
01-01-2008 · EurekAlert!
New research at Wake Forest University Baptist Medical Center suggests that a three-drug cocktail may one day improve outcomes in patients with glioblastoma multiforme, a type of brain tumor with a dismal prognosis. Two of the drug candidates have been developed, and the team is working on the third -- all targeted to kill or impair cancer cells and spare healthy brain.
Similar news · Read more »
- Combining NSAIDs with chemotherapy, radiation may improve cancer treatment
05-17-2007 · EurekAlert!
Certain nonsteroidal anti-inflammatory drugs may be better suited to treating cancer, in combination with standard therapies, rather than preventing it, according to new research by scientists at the University of Iowa Roy J. and Lucille A. Carver College of Medicine.
Similar news · Read more »
- Altered expression of ultraconserved noncoding RNAs linked to human leukemias and carcinomas
09-10-2007 · EurekAlert!
A new study provides evidence that noncoding RNAs and interactions between noncoding genes play a much greater role in human cancer than was previously understood. The research, published by Cell Press in the September issue of the journal Cancer Cell, may be useful for identifying tumor-specific signatures associated with diagnosis, prognosis and treatment of cancer.
Similar news · Read more »
- Studies suggest key correlation between lung cancer subtype and treatment outcomes
09-26-2007 · EurekAlert!
In clinical research, patients with advanced non-small cell lung cancer that are classified as having a non-squamous histology achieve statistically significant higher survival when treated in the second-line setting with ALIMTA (pemetrexed for injection) when compared to histologically-similar patients treated with docetaxel.
Similar news · Read more »
- PET imaging may improve lung cancer diagnosis
11-27-2007 · EurekAlert!
Tumor imaging with positron emission tomography may improve the diagnosis and subsequent treatment of lung cancer patients, according to a review published online Nov. 27 in the Journal of the National Cancer Institute.
Similar news · Read more »
- Other highlights in the Aug. 7 JNCI
08-07-2007 · EurekAlert!
Also in the Aug. 7 JNCI are a study showing vitamins and minerals do not improve liver cancer survival, another study on testicular cancer survivors' survival rates for second cancers, a gene expression pattern that predicts lung cancer prognosis and epigenetic changes in Wilms tumor.
Similar news · Read more »
- Study indicates pregnancy does not harm chances of survival from cancer
09-27-2007 · EurekAlert!
New research offers reassurance to women worried about whether getting pregnant after cancer treatment might worsen their prognosis.
Similar news · Read more »
- Enhancing chemotherapy's efficacy: new agent has synergistic effect with standard drugs
04-15-2007 · EurekAlert!
Integrating the use of drugs targeted to specific cancer proteins into current chemotherapy regimens to improve the efficacy of systemic treatment is an important clinical goal. Fox Chase Cancer Center research presented during AACR has found that a new chemical agent, MCP110, has a synergistic effect both in vitro and in vivo when used with current chemotherapy drugs such as taxanes (Taxol and Taxotere) and vinca-alkaloid compounds such as vincristine.
Similar news · Read more »
- Genetic analyis for personalizing of treatment of lung and colon cancer, certain sarcomas
03-05-2007 · EurekAlert!
Genetic analysis has enabled the personalising of the pharmaceutical treatment of patients with cancer, enhancing thereby therapeutic efficacy and minimising possible toxicity. In concrete, the Biotechnology Laboratory team at the University Hospital (University of Navarra), in close collaboration with the Pharmacogenomics laboratory at the Centre for Applied Medical Research of the same university, undertook these analyses predictive of responses to pharmaceutical drugs in patients with cancer of the lung, the colon and certain types of sarcoma.
Similar news · Read more »
- Research suggests omega-3s may help slow prostate cancer growth
06-21-2007 · EurekAlert!
Research in mice suggests that a diet high in omega-3 fatty acids found in fish oil and certain types of fish could potentially improve the prognosis of men who are genetically prone to develop prostate cancer.
Similar news · Read more »
